Page last updated: 2024-11-03

ag 1879 and Acute Promyelocytic Leukemia

ag 1879 has been researched along with Acute Promyelocytic Leukemia in 3 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Research Excerpts

ExcerptRelevanceReference
"An all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) combination yields high-quality remission and survival in newly-diagnosed acute promyelocytic leukemia (APL)."7.80Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide. ( Cheong, HJ; Jung, YS; Kim, KH; Kim, SJ; Lee, N; Park, HS; Won, JH, 2014)
"An all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) combination yields high-quality remission and survival in newly-diagnosed acute promyelocytic leukemia (APL)."3.80Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide. ( Cheong, HJ; Jung, YS; Kim, KH; Kim, SJ; Lee, N; Park, HS; Won, JH, 2014)
"While acute promyelocytic leukemia (APL) patients are highly responsive to retinoic acid (RA) therapy, kinase inhibitors have been gaining momentum as co-treatments with RA for non-APL acute myeloid leukemia (AML) differentiation therapies, especially as a means to treat relapsed or refractory AML patients."1.42GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation. ( Bunaciu, RP; Jensen, HA; Varner, JD; Yen, A, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, YS1
Cheong, HJ1
Kim, SJ1
Kim, KH1
Lee, N1
Park, HS1
Won, JH1
Jensen, HA1
Bunaciu, RP1
Varner, JD1
Yen, A1
Jones, JE1
Wang, L1
Kropf, PL1
Duan, R1
Johnson, DE1

Other Studies

3 other studies available for ag 1879 and Acute Promyelocytic Leukemia

ArticleYear
Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Leukemia research, 2014, Volume: 38, Issue:8

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; CD11b Antigen; Cell Differentiation; Cell Line, Tumor; Drug

2014
GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation.
    Cellular signalling, 2015, Volume: 27, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD11b Antigen; Cell Different

2015
Src family kinase gene targets during myeloid differentiation: identification of the EGR-1 gene as a direct target.
    Leukemia, 2009, Volume: 23, Issue:10

    Topics: Antineoplastic Agents; Cell Differentiation; Early Growth Response Protein 1; Gene Expression Profil

2009